He currently serves as Chief Operating Officer of Okairos, a biopharmaceutical company developing genetic vaccines for major infectious diseases. Previously Tom co-founded EuroVentures, a wholly owned biotech incubator within Versant Ventures. In this role, Tom shaped the formation of four start-up companies: Flexion, Synosia, Sentient, and Amira. As the founding Chief Business Officer for each of these companies, Tom negotiated over 20 different license agreements with six major pharmaceutical companies and helped raise over $100 million in equity capital. Prior to co-founding Euro Ventures, Tom was a Principal at Versant Ventures and served on the boards of Antipodean, Metabolex and Saegis. Tom was a research scientist at XenoPort before joining Versant.
Tom earned his PhD in Organic Chemistry as an NSF Fellow at Stanford University and graduated summa cum laude with a BA in English and received the Departmental Citation for his BSc in Chemistry from UC Berkeley.